User login
Zevallos JP, Kramer JR, Sandulache VC et al. National trends in oropharyngeal cancer incidence and survival within the Veterans Affairs Health Care System. Head Neck. 2021;43(1):108-115. doi:10.1002/hed.26465
Goodwin CE. Oral cavity and pharynx cancers, active component, U.S. Armed Forces, 2007-2019. MSMR. 2021;28(7):11-14. https://health.mil/News/Articles/2021/07/01/Oral-Cavity-MSMR
Elhalawani H, Mohamed ASR, Elgohari B, et al. Tobacco exposure as a major modifier of oncologic outcomes in human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma. BMC Cancer. 2020;20(1):912. doi:10.1186/s12885-020-07427-7
Jurica JM, Rubio F, Hernandez DJ, Sandulache VC. Institutional financial toxicity of failure to adhere to treatment guidelines for head and neck squamous cell carcinoma. Head Neck. 2021;43(3):816-824. doi:10.1002/hed.26539
Centers for Disease Control and Prevention. HPV infection. Updated July 23, 2021. Accessed December 9, 2021. https://www.cdc.gov/hpv/parents/about-hpv.html
D’Souza G, McNeel TS, Fakhry C. Understanding personal risk of oropharyngeal cancer: risk-groups for oncogenic oral HPV infection and oropharyngeal cancer. Ann Oncol. 2017;28(12):3065-3069. doi:10.1093/annonc/mdx535phary
Clark LL, Stahlman S, Taubman SB. Human papillomavirus vaccine initiation, coverage, and completion rates among U.S. active component service members, 2007-2017. MSMR. 2018;25(9):9-14. https://pubmed.ncbi.nlm.nih.gov/30272988/
US Food and Drug Administration. Gardasil 9. Updated August 21, 2020. Accessed December 9, 2021. https://www.fda.gov/vaccines-blood-biologics/vaccines/gardasil-9
Zevallos JP, Kramer JR, Sandulache VC et al. National trends in oropharyngeal cancer incidence and survival within the Veterans Affairs Health Care System. Head Neck. 2021;43(1):108-115. doi:10.1002/hed.26465
Goodwin CE. Oral cavity and pharynx cancers, active component, U.S. Armed Forces, 2007-2019. MSMR. 2021;28(7):11-14. https://health.mil/News/Articles/2021/07/01/Oral-Cavity-MSMR
Elhalawani H, Mohamed ASR, Elgohari B, et al. Tobacco exposure as a major modifier of oncologic outcomes in human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma. BMC Cancer. 2020;20(1):912. doi:10.1186/s12885-020-07427-7
Jurica JM, Rubio F, Hernandez DJ, Sandulache VC. Institutional financial toxicity of failure to adhere to treatment guidelines for head and neck squamous cell carcinoma. Head Neck. 2021;43(3):816-824. doi:10.1002/hed.26539
Centers for Disease Control and Prevention. HPV infection. Updated July 23, 2021. Accessed December 9, 2021. https://www.cdc.gov/hpv/parents/about-hpv.html
D’Souza G, McNeel TS, Fakhry C. Understanding personal risk of oropharyngeal cancer: risk-groups for oncogenic oral HPV infection and oropharyngeal cancer. Ann Oncol. 2017;28(12):3065-3069. doi:10.1093/annonc/mdx535phary
Clark LL, Stahlman S, Taubman SB. Human papillomavirus vaccine initiation, coverage, and completion rates among U.S. active component service members, 2007-2017. MSMR. 2018;25(9):9-14. https://pubmed.ncbi.nlm.nih.gov/30272988/
US Food and Drug Administration. Gardasil 9. Updated August 21, 2020. Accessed December 9, 2021. https://www.fda.gov/vaccines-blood-biologics/vaccines/gardasil-9
Zevallos JP, Kramer JR, Sandulache VC et al. National trends in oropharyngeal cancer incidence and survival within the Veterans Affairs Health Care System. Head Neck. 2021;43(1):108-115. doi:10.1002/hed.26465
Goodwin CE. Oral cavity and pharynx cancers, active component, U.S. Armed Forces, 2007-2019. MSMR. 2021;28(7):11-14. https://health.mil/News/Articles/2021/07/01/Oral-Cavity-MSMR
Elhalawani H, Mohamed ASR, Elgohari B, et al. Tobacco exposure as a major modifier of oncologic outcomes in human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma. BMC Cancer. 2020;20(1):912. doi:10.1186/s12885-020-07427-7
Jurica JM, Rubio F, Hernandez DJ, Sandulache VC. Institutional financial toxicity of failure to adhere to treatment guidelines for head and neck squamous cell carcinoma. Head Neck. 2021;43(3):816-824. doi:10.1002/hed.26539
Centers for Disease Control and Prevention. HPV infection. Updated July 23, 2021. Accessed December 9, 2021. https://www.cdc.gov/hpv/parents/about-hpv.html
D’Souza G, McNeel TS, Fakhry C. Understanding personal risk of oropharyngeal cancer: risk-groups for oncogenic oral HPV infection and oropharyngeal cancer. Ann Oncol. 2017;28(12):3065-3069. doi:10.1093/annonc/mdx535phary
Clark LL, Stahlman S, Taubman SB. Human papillomavirus vaccine initiation, coverage, and completion rates among U.S. active component service members, 2007-2017. MSMR. 2018;25(9):9-14. https://pubmed.ncbi.nlm.nih.gov/30272988/
US Food and Drug Administration. Gardasil 9. Updated August 21, 2020. Accessed December 9, 2021. https://www.fda.gov/vaccines-blood-biologics/vaccines/gardasil-9
